Mutant Prevention Concentrations of Doripenem and Meropenem Alone and in Combination with Colistin (Polymyxin E), Levofloxacin and Tobramycin in Pseudomonas aeruginosa
BACKGROUND: With a limited number of available antimicrobial agents to treat Pseudomonas aeruginosa infections, the prevention of emergence of antimicrobial resistance and its subsequent spread is critical. In the present study, the mutant prevention concentration (MPC) of doripenem was examined and...
Saved in:
Main Authors: | George G Zhanel, Vibhu Vishisht, Ed Tam, Daryl J Hoban, James A Karlowsky |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2009/801612 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Vitro Activities of Ceftobiprole and Doripenem Tested against Frequently Encountered Aerobic and Facultative Gram-Positive and Gram-Negative Bacterial Pathogens Isolated from Patients in Canadian Hospitals in 2007
by: James A Karlowsky, et al.
Published: (2009-01-01) -
Mutant Prevention Concentrations of Imipenem and Meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii
by: E. Dahdouh, et al.
Published: (2014-01-01) -
Ciprofloxacin or Imipenem Use Correlates with Resistance in Pseudomonas aeruginosa
by: George G Zhanel, et al.
Published: (1998-01-01) -
Utilization of Colistin for Treatment of Multidrug-Resistant Pseudomonas aeruginosa
by: Deana M Sabuda, et al.
Published: (2008-01-01) -
Cefazolin Alone Versus Cefazolin With Tobramycin or Gentamicin as Intraoperative Antibiotic Prophylaxis for Total Joint Arthroplasty
by: Meera M. Dhodapkar, MD, MHS, et al.
Published: (2025-02-01)